TEX26
gene geneOn this page
Also known as MGC40178
Summary
TEX26 (testis expressed 26, HGNC:28622) is a protein-coding gene on chromosome 13q12.3, encoding Testis-expressed protein 26 (Q8N6G2).
Predicted to be active in cytoplasm.
Source: NCBI Gene 122046 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 61 total
- Dosage sensitivity (ClinGen): haploinsufficiency dosage sensitivity unlikely, triplosensitivity no evidence
- MANE Select transcript:
NM_152325
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28622 |
| Approved symbol | TEX26 |
| Name | testis expressed 26 |
| Location | 13q12.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC40178 |
| Ensembl gene | ENSG00000175664 |
| Ensembl biotype | protein_coding |
| Entrez | 122046 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 4 protein_coding, 2 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
ENST00000380473, ENST00000479195, ENST00000530916, ENST00000531960, ENST00000906072, ENST00000944411, ENST00000944412
RefSeq mRNA: 5 — MANE Select: NM_152325
NM_001353388, NM_001353389, NM_001353390, NM_001353391, NM_152325
CCDS: CCDS9339
Canonical transcript exons
ENST00000380473 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001221318 | 30952660 | 30952825 |
| ENSE00001221322 | 30939694 | 30939778 |
| ENSE00001485094 | 30974846 | 30975500 |
| ENSE00003529363 | 30932656 | 30932776 |
| ENSE00003551000 | 30968885 | 30969046 |
| ENSE00003604543 | 30956873 | 30957029 |
| ENSE00003673381 | 30966222 | 30966398 |
Expression profiles
Bgee: expression breadth ubiquitous, 142 present calls, max score 97.51.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.5866 / max 69.9182, expressed in 165 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 134645 | 0.3067 | 108 |
| 134646 | 0.2799 | 110 |
Top tissues by expression
241 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 97.51 | gold quality |
| bronchial epithelial cell | CL:0002328 | 91.60 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 91.07 | gold quality |
| left testis | UBERON:0004533 | 90.56 | gold quality |
| right testis | UBERON:0004534 | 90.03 | gold quality |
| bronchus | UBERON:0002185 | 89.78 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 89.19 | gold quality |
| testis | UBERON:0000473 | 87.74 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 85.98 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 78.15 | gold quality |
| adult organism | UBERON:0007023 | 77.69 | gold quality |
| ventricular zone | UBERON:0003053 | 75.87 | gold quality |
| hypothalamus | UBERON:0001898 | 75.62 | gold quality |
| ganglionic eminence | UBERON:0004023 | 71.62 | gold quality |
| adenohypophysis | UBERON:0002196 | 68.72 | gold quality |
| nucleus accumbens | UBERON:0001882 | 68.52 | gold quality |
| buccal mucosa cell | CL:0002336 | 67.67 | silver quality |
| nasal cavity mucosa | UBERON:0001826 | 67.36 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 66.17 | gold quality |
| pituitary gland | UBERON:0000007 | 65.38 | gold quality |
| caudate nucleus | UBERON:0001873 | 65.06 | gold quality |
| amygdala | UBERON:0001876 | 64.39 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 64.32 | gold quality |
| prefrontal cortex | UBERON:0000451 | 63.15 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 62.43 | gold quality |
| spinal cord | UBERON:0002240 | 62.13 | gold quality |
| tibialis anterior | UBERON:0001385 | 61.88 | silver quality |
| putamen | UBERON:0001874 | 61.19 | gold quality |
| forebrain | UBERON:0001890 | 60.02 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 59.73 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.38 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
7 targeting TEX26, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-579-3P | 99.86 | 71.66 | 3628 |
| HSA-MIR-664B-3P | 99.84 | 71.65 | 3590 |
| HSA-MIR-580-3P | 99.67 | 69.23 | 1841 |
| HSA-MIR-3942-3P | 99.57 | 69.03 | 2854 |
| HSA-MIR-502-5P | 98.77 | 66.51 | 906 |
| HSA-MIR-2115-5P | 98.66 | 68.07 | 1191 |
| HSA-MIR-10397-5P | 97.31 | 69.06 | 710 |
Functional genomics
ClinGen dosage: haploinsufficiency 40 (dosage sensitivity unlikely), triplosensitivity 0 (no evidence). ClinGen Gene Dosage Map
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Tex26 | ENSMUSG00000029660 |
| rattus_norvegicus | Tex26 | ENSRNOG00000000905 |
Protein
Protein identifiers
Testis-expressed protein 26 — Q8N6G2 (reviewed: Q8N6G2)
All UniProt accessions (2): Q8N6G2, H0YE92
RefSeq proteins (5): NP_001340317, NP_001340318, NP_001340319, NP_001340320, NP_689538* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR043460 | MEDAG/TEX26 | Family |
UniProt features (8 total): region of interest 6, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N6G2-F1 | 63.42 | 0.01 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 26 (showing top):
GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_DN, DARWICHE_PAPILLOMA_PROGRESSION_RISK, CDP_01, TGGAAA_NFAT_Q4_01, DODD_NASOPHARYNGEAL_CARCINOMA_DN, HATADA_METHYLATED_IN_LUNG_CANCER_UP, MIR3942_3P, MIR2115_5P, GSE14350_TREG_VS_TEFF_IN_IL2RB_KO_DN, DESCARTES_MAIN_FETAL_CILIATED_EPITHELIAL_CELLS, DESCARTES_FETAL_LUNG_CILIATED_EPITHELIAL_CELLS, TRAVAGLINI_LUNG_PROXIMAL_CILIATED_CELL, CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_DN, GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_DN, GSE39820_IL1B_IL6_VS_IL1B_IL6_IL23A_TREATED_CD4_TCELL_UP
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
246 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TEX26 | SYNGR4 | O95473 | 644 |
| TEX26 | TEX2 | Q8IWB9 | 507 |
| TEX26 | TEX22 | C9J3V5 | 507 |
| TEX26 | TEX261 | Q6UWH6 | 506 |
| TEX26 | FAM241B | Q96D05 | 506 |
| TEX26 | PLEKHB1 | Q9UF11 | 505 |
| TEX26 | MXD3 | Q9BW11 | 496 |
| TEX26 | OR2I1 | Q8NGU4 | 480 |
| TEX26 | TEX9 | Q8N6V9 | 435 |
| TEX26 | CYTL1 | Q9NRR1 | 416 |
| TEX26 | TEX19 | Q8NA77 | 398 |
| TEX26 | SPEF1 | Q9Y4P9 | 393 |
| TEX26 | PDIA2 | Q13087 | 391 |
| TEX26 | KATNAL1 | Q9BW62 | 381 |
| TEX26 | F2RL3 | Q96RI0 | 367 |
| TEX26 | SPATA4 | Q8NEY3 | 367 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A087WRI3, A2BFC9, A2RRW4, A4QMS7, A6NJV1, A6NL82, A6QPC0, A6QQ68, A8E4X8, A8E5W8, A8QW39, A9JS51, D6REC4, F1P3Y5, G3X6E2, P0C875, Q0VB26, Q1MSJ5, Q2IA00, Q2T9Q3, Q2TA11, Q3UY96, Q494V2, Q497Q6, Q4KKZ1, Q4QR77, Q4R5Y0, Q4R8V8, Q5NC57, Q5ZIH9, Q6J272, Q6PII3, Q6ZQR2, Q6ZVS7, Q7Z4T9, Q8CFW7, Q8N1D5, Q8N6G2, Q8WW14, Q95LR0
Diamond homologs: Q0VB26, Q8N6G2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
61 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 55 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1173 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 13:30932777:G:GG | donor_gain | 1.0000 |
| 13:30932772:GCCAA:G | donor_gain | 0.9900 |
| 13:30952658:A:AG | acceptor_gain | 0.9900 |
| 13:30952659:G:GG | acceptor_gain | 0.9900 |
| 13:30952823:G:GT | donor_gain | 0.9900 |
| 13:30952823:GAA:G | donor_gain | 0.9900 |
| 13:30952826:G:GG | donor_gain | 0.9900 |
| 13:30960132:G:GT | donor_gain | 0.9900 |
| 13:30966215:A:AG | acceptor_gain | 0.9900 |
| 13:30966216:C:G | acceptor_gain | 0.9900 |
| 13:30966220:A:AG | acceptor_gain | 0.9800 |
| 13:30966221:G:GG | acceptor_gain | 0.9800 |
| 13:30968883:A:AG | acceptor_gain | 0.9800 |
| 13:30968884:G:GG | acceptor_gain | 0.9800 |
| 13:30932775:AA:A | donor_gain | 0.9700 |
| 13:30932776:AG:A | donor_loss | 0.9700 |
| 13:30932777:GTAA:G | donor_loss | 0.9700 |
| 13:30932778:T:A | donor_loss | 0.9700 |
| 13:30952831:A:G | donor_gain | 0.9700 |
| 13:30974845:GATA:G | acceptor_gain | 0.9700 |
| 13:30952659:GCC:G | acceptor_gain | 0.9600 |
| 13:30952659:GCCA:G | acceptor_gain | 0.9500 |
| 13:30952823:GAAG:G | donor_loss | 0.9500 |
| 13:30952824:AAGT:A | donor_loss | 0.9500 |
| 13:30952825:AG:A | donor_loss | 0.9500 |
| 13:30952826:GTAAG:G | donor_loss | 0.9500 |
| 13:30952827:T:TC | donor_loss | 0.9500 |
| 13:30966392:GGTC:G | donor_gain | 0.9500 |
| 13:30932774:CAA:C | donor_gain | 0.9400 |
| 13:30952821:ATGAA:A | donor_gain | 0.9400 |
AlphaMissense
1906 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 13:30939741:T:C | F37L | 0.973 |
| 13:30939743:C:A | F37L | 0.973 |
| 13:30939743:C:G | F37L | 0.973 |
| 13:30957011:T:C | F151L | 0.949 |
| 13:30957013:T:A | F151L | 0.949 |
| 13:30957013:T:G | F151L | 0.949 |
| 13:30966296:T:C | F182L | 0.944 |
| 13:30966298:C:A | F182L | 0.944 |
| 13:30966298:C:G | F182L | 0.944 |
| 13:30956987:T:C | F143L | 0.930 |
| 13:30956989:T:A | F143L | 0.930 |
| 13:30956989:T:G | F143L | 0.930 |
| 13:30966300:G:C | R183P | 0.896 |
| 13:30974866:T:C | F277L | 0.876 |
| 13:30974868:T:A | F277L | 0.876 |
| 13:30974868:T:G | F277L | 0.876 |
| 13:30966392:G:C | G214R | 0.875 |
| 13:30952740:A:C | Y76S | 0.858 |
| 13:30974867:T:C | F277S | 0.856 |
| 13:30939742:T:C | F37S | 0.851 |
| 13:30939724:C:T | T31I | 0.847 |
| 13:30968885:T:A | V216E | 0.833 |
| 13:30956972:G:C | A138P | 0.832 |
| 13:30969026:T:C | L263P | 0.831 |
| 13:30952745:T:A | W78R | 0.825 |
| 13:30952745:T:C | W78R | 0.825 |
| 13:30952739:T:G | Y76D | 0.817 |
| 13:30966308:T:G | Y186D | 0.816 |
| 13:30956885:T:A | W109R | 0.814 |
| 13:30956885:T:C | W109R | 0.814 |
dbSNP variants (sampled 300 via entrez): RS1000009977 (13:30957401 G>A), RS1000076530 (13:30956351 T>C), RS1000124541 (13:30952261 T>A,C), RS1000136541 (13:30968803 G>A,C), RS1000196317 (13:30975456 C>T), RS1000211460 (13:30943404 A>C), RS1000212502 (13:30945727 T>A,C), RS1000289005 (13:30937558 T>C), RS1000461199 (13:30953456 C>T), RS1000512982 (13:30953202 C>T), RS1000553065 (13:30948975 C>A,T), RS1000598610 (13:30937714 A>G), RS1000617220 (13:30954538 A>G), RS1000707200 (13:30954346 G>A,T), RS1000794392 (13:30964844 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010396_269 | Gut microbiota (bacterial taxa, hurdle binary method) | 4.000000e-07 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007874 | gut microbiome measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cadmium Chloride | increases expression | 2 |
| sodium arsenite | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.